Page 1

IPT JOURNAL Official E-Magazine Members Only European Academy for Insulin Potentiation Therapy

issue 3 - May 2019

MAY

TH

IR

D

IS

SU

E


ACADEMY BOARD OF DIRECTIVES

Donato Perez Garcia, MD

Honorary President Director Board of Education

Thomas Kroiss, MD

CONTENT: Letter From Our President History of the academy

Founder of the Academy

Martin Von Rosen, MD

academy goals and purpose

President

Arman Lurye, MD VicePresident

Rebecca Ayre-Stealey, RN Treasurer

7-question interview: IPT and Nurses What’s NEW on IPT Dr. Donato?

Catalin Cirstoveanu Secretary

What it Means to Be an IPT Physician?

Irina Lurye Revisor

Jessica Ferrari

Executive Assistant IPT Journal Editor /Designer

A New Treatment Method of Advanced Metastatic Tumors by Dr. Damyanov Christo

All rights reserved. No part of this publication may be reproduced in whole or in part, or stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted under Sections 107 or 108 of the 1976 United States Copyright Act, without either the prior permission of the Publisher, or authorization through payment of the appropriate per-copy fee. Requests to the Publisher for permission should be addressed to the Permission Department, IPT JOURNAL. Blvd. Diaz Ordaz No.12415 M1-10 Fracc. El Paraiso C.P. 22106. Tijuana,B.C. Mexico or email info@iptldacademy.org. IPTlD® is a Registered TRADEMARK by Donato Perez Garcia, MD. The IPT JOURNAL has a license/permission to use IPT/IPTLD® materials given by Donato Perez Garcia. NOTE; Some images used in this electronic publication were downloaded, and/or edited following each photo requirements or paid, from the internet. All are copyright protected and they are not property of the European Academy for Insulin Potentiation Therapy. This journal may include medical essays or referals from other authors outside of the IPT Academy Members as mere scientific reference but they are not property of the IPT Journal. Copyright © 2019 IPTJOURNAL. Copyright © 2019 The European Academy for Insulin Potentiation Therapy.

2019 IPT Global Conference in Fulda 2019 Traning Workshops and Seminars


Newsletter from our Academy President: The program for the fall-conference in Fulda/Germany on Oct 4th through 6th is nearly complete. We have interesting topics and renowned speakers confirmed. Prof. Blaurock-Busch, owner of the lab microtrace minerals https://microtrace.de/en/home/ has published many articles on Chelation / Heavy metals. You will find lots of information in many languages on her website. Prof. Bojar has worked at the University of Düsseldorf and will give us an overview in Molecular Mimetic and strategy finding in moderncancertherapy. https://www.prof-bojar.de/en/

We will also have a session with “best cases“ and cases where the patients didn´t respond well or long with IPTLD®. that´s where we will learn the most and that´s why we should meet regularly and exchange our knowledge and experiences. I will welcome you to Fulda. October 3rd is holiday in Germany. We celebrate the unification of the 2 German states in 1990, so it´s worth to fly inn earlier and stay a bit longer in Fulda. There is a border museum 20’ away (by car) which is very interesting especially nowadays where division between east and west is growing on the political side. The landscape around Fulda is called “Rhön”, one of the highlands in Germany, very smooth, very rough, very nice. The weather normally is stable in October. The highest top is “Wasserkuppe” Mekka and cradle of gliders worldwide.

Professor Thomas Vogl is head of the department for interventional radiology at the University in Frankfurt. His topic will be TACE and LITT in managing metastatic lesions. Dr. Nesselhut has lots of experience in unconventional cancer treatment for example with “dendritic cells”. He’ll be giving us a lecture in "Combination of low-dose checkpoint inhibitor therapy with other immunotherapies (dendritic cells, virotherapy). We will hear about albumin-bound / enhanced MTX (MTX-HSA) in a presentation from Dr. Fritz Trennheuser (pharmacist). That will be especially interesting because one of the view studies with IPTLD® is made with conventional MTX many years ago. Regelsberger has found that cyclophosphamide could be enhanced with intravenous oxygen. Dr. Wiechert is head of the German association and will give us his presentation on “Oxygen” as a supplement in complementary cancer therapy. http://www.oxyven.de/en/ From our own group Geoffrey has offered to talk about “Metronomic Chemotherapy between the IPTLD’s”. Leonid will give us insight in "intranasal application of stem cells“ which will give us many possibilities to help patients in future.

Regards, Dr. Martin Von Rosen Academy President

Our next Video Conference (ViCo) call will be Sunday May 12th at 5:00 pm Central European Time, you are all welcome to join. You’ll be receiving some email reminders and link to register step by step to our Academy Teams Group. For all members who haven’t joined I encourage you to do so, we can do a test call one day prior to our ViCo, send me an email so I can add you to our group. We are discussing last details on our conference program and discussing the current treatment guidelines for CLL / chronic lymphatic leukemia. I invite all members to discuss any medical inquiries or share your valuable experience with us, we are all here to learn. And finally to announce that the Official IPT Physicians Directory of the EAIPT is now on the German Homepage https://www.ipt-insulin-potenzierte-therapie.info/de/ I encourage members who haven’t sent their updated information to please contact Jessica so she may include you in the Academy’s web page directory.


History of the European Academy for Insulin Potentiation Therapy

by Thomas Kroiss, MD

Founder of the Academy for IPT

I made my first IPT seminar with Dr. Donato in the year 2003. There I learned to perform IPT on my patients. I went home and had very good successes! Fortunately, at that time we were three doctors from Germany/Austria so we could talk on the telephone about patients and problems and so one could be helped by the other. From then on, I visited the annual conference every time since 2003 and had to realize that I needed to correct my procedure through the first 4 years because there were always a number of things I had overlooked so far; in this way I improved my treatments every year. – That was the first time I realized how important it would be to have a profound education by an Academy and to have group of expert doctors helping each other.

When I heard of the American doctors who turned their backs on Dr. Donato and behaved as if they had invented IPT and even trained other doctors in the name of IPT I decided that this must not happen in Europe! So I founded an international academy (which was possible in Austria, in Germany it was only possible to found a national association). My first action was to set up Dr. Donato as the lifetime Honorary President in the constitutional charter so nobody would ever be able to come along and take over for his own profit. Unfortunately, we could not do anything against doctors who just heard about using insulin together with chemotherapeutic agents in cancer cases and using the name “IPT” for doing so.

They were and are not really doing IPT and factually using a false name (“IPT”). Also I found that we sometimes had educated bad doctors who were not doing the correct medical procedures besides IPT. Both things were a certain danger for IPT itself but one cannot force people to be well educated; we could only provide good education on a voluntary basis. This is where we stand. In 2014, we had sufficient money on our account and we had a considerable number of active members in Europe so I retired as the president. I hope that from now on the Academy will be keeping up the high standard of educating and performing IPT. I wish you all the best!


What is the European Academy for Insulin Potentiation Therapy? We are a European civil association of medical doctors and healthcare professionals, officially certified in the medical protocol of Insulin Potentiation Therapy, taught by Donato Pérez García (legal proprietor of intellectual knowledge in this therapy and living grandson of the rightful discoverer). The Academy is integrated by doctors from over 18 countries, joined by a common goal to practice IPT/IPLD® within the ethic codes and scientific principles of its founder for the betterment and wellbeing of patients worldwide. Our Academy seeks to attend all ethical, professional, scientific and business related necessities related to the protocol IPT/IPTLD® and its members all over the globe, we are a support community and social alliance for all certified members; sharing our mutual experience and scientific knowledge, training medical doctors, natural and homeopathic doctors, nurses even vet nary doctors, clinics and hospitals so they may offer IPT/IPTLD® as a holistic healing therapy to patients, we offer training tools like seminars, conferences and training workshops to keep our IPT Physicians updated and sharp so they may administer IPT?IPTLD® with excellence. The Academy was also founded as a preventive association towards the high growing problem concerning IPT Piracy from doctors and institutions offering an alleged version of IPT but are not properly trained nor do they hold consent from the proprietor of intellectual knowledge, Dr. Donato Pérez García. One of the academyʼs main goal is to alert patients concerning dangers in consulting or receiving “IPT” from non-officially certified doctors, putting patientʼs wellbeing and security above all. The European Academy for Insulin Potentiation Therapy represents over 80 years of history in propagating the discovery of the Mexican military doctor Donato Pérez García, Sr. (1896-1971) that throughout 3 generations have preserved this knowledge and offers it to that seek to learn an alternative healing method, specially to cancer patients.


7-Question Interview with Rebecca Ayre Stealey: “IPT and Nurses” IPTJOURNAL: Rebecca, thank you so much for accepting this interview, congratulations by the way in receiving the honorary IPT Award on behalf of your father, Steven G. Ayre. We have a special interview just for you. How long have you’ve been a registered nurse and where did you receive IPT training? Rebecca: I became licensed as an RN in February 2014 after deciding that a nursing career would be of value, after moving on from a possible career in high school education. I trained in IPT by working side-by-side with my father, Steven Ayre MD since Fall 2011. He was a family physician and took great satisfaction in administering treatments by himself, and sitting by the patient’s side throughout the treatments, deepening their therapeutic relationship and guiding them towards healing on a deeper level. IPT is unique in that patient’s voluntarily enter into a state of vulnerability. It is scary and unnerving, but they know that is what they must do to heal. In the end, bravery always carries them through. My dad was big into quotes, and what I learned from my training in IPT from my Dad is best summarized by the following: “Come to the edge," he said. "We can't, we're afraid!" they responded. "Come to the edge," he said.

“It is scary and natural to have doubts, but when we have faith in the process and healing techniques, together we can fly. ”

"We can't, we will fall!" they responded. "Come to the edge," he said. And so they came. And he pushed them. And they flew.” -Guillaume ApollinaireOftentimes, our patients feel they have come to the edge of what they know they can do. It is scary and natural to have doubts, but when we have faith in the process and healing techniques, together we can fly. IPTJOURNAL: When and how did you come to know about Insulin Potentiation Therapy? Rebecca: When I was 8 years old my dad brought up IPT in conversation we were having in the car. I asked him what it was. He explained the biology and mechanism of action of insulin as best he could in terms a child would understand, and I got it. It made sense to me. And I think that is another great appeal of IPT. That one does not have to be an expert in biology or cancer therapy to understand the basics of why and how IPT works. I know that people diagnosed with cancer quickly have to become experts in things that they likely didn’t ever want to know about. And the pressure to “get it right” is pretty intense when faced with what could make the difference between living and dying. IPT is something that resonates with people because the basics of it make sense, on an intuitive and biological level.


IPTJOURNAL: What was the appeal of learning IPT/IPTLD®? Rebecca: The appeal was being able to journey with somebody from a place of what can be suffering, pain, and fear to a place of joy and a return to a love of life. I imagine this is the appeal to many practitioners who work in cancer care. I chose to focus on the area of IPT because I saw firsthand with my dad the beauty of the transformation to health that is possible with patients. Of course no therapy is effective 100% of the time for 100% of people, but I make it my goal for every one of our patients to benefit so that we improve the quality and duration of their lives, in smaller or larger ways. IPTJOURNAL: Curious fact is that you’re the only Registered Nurse in the Academy, we tend to see more MD’s in IPT, in your opinion, why is it uncommon for nurses to seek IPT Training? Rebecca: I think that it is simply a matter of not knowing about IPT. IPTJOURNAL: Do you know of other nurses trained in IPT? Rebecca: My coworker Jeanette Barczak RN administers IPT at our clinic. Her background is in pediatric cardiology but was drawn to more a more holistic approach to patient care than what is typically delivered during a hospital stay, achieving certification in Aromatherapy and Healing Touch. I can’t speak directly for her, but I know she is devoted to being able to provide IPT within a holistic context to our patients. IPTJOURNAL: Do you know of other nurses trained in IPT?

“IPT is something that resonates with people because the basics of it make sense, on an intuitive and biological level”.

I am a member of both the American Holistic Nursing Society and the Oncology Nursing Society. Both organizations have well attended yearly conferences. Once I’m through with school (I’m working towards my Master’s of Science in Nursing for the next two years) I would love to present on IPT at either or both of these conferences to share my experiences with IPT, and a holistic approach to cancer care. IPTJOURNAL: What’s been the most rewarding part of your career? Rebecca: The most rewarding part of my career is by far the relationships I share with my patients. I really cherish our relationships – both for what they share with me and what I earn from them. To employ another quote: “How beauteous mankind is! Oh brave new world, that has such people in it!” IPTJOURNAL: Thank you for sharing such valuable life experience with us, Rebecca, we hope to see you on our next Conference in Fulda!

Watch Rebeccaʼs Interview https://www.youtube.com/watch?v=mvZT0sm3c9s Dear Academy member, we’d like to publish your 7-question interview, please send us your request for the next issue. all members are welcome to participate. write to us also if you have interview theme suggestions.

YOUR 7-QUESTION INTERVIEW HERE Write to us: education@iptldacademy.org


EDUCATION IS FOREVER and ever ...

and ever ... and ever ...

when you’re a Medical Doctor Why Not Learn Insulin Potentiation Therapy? - 5 day training course - Become an IPT Physician - Join the IPT Academy - Welcome to the family

www.donatoperezgarcia.com


What’s NEW on IPT Dr.Donato?

What causes chemotherapy drug resistance? The presence or development of resistance to anticancer drugs is the main cause of failure of chemotherapy in the majority of the most common forms of cancer (e.g., lung, colon, breast). Resistance to chemotherapeutic drugs can be already present at diagnosis or it can develop after treatment with standard high dose chemotherapy. These two forms of drug resistance are respectively called intrinsic and acquired. It is unknown whether the underlying mechanisms of drug resistance are the same in these two forms of drug resistance. Many causes of drug resistance are well recognized, such as those due to administration of inadequate doses or scheduling of the drug, or to altered pharmacokinetics, or to limited penetration of the drug into the tumor.

Limited penetration may be caused by poor vascularization, or extensive necrosis of parts of the tumor. It can also be due to localization of the tumor in areas of the body which are difficult to reach (sanctuary sites) because of the presence of a tissue-blood barrier (e.g., blood-brain, blood-testis, placenta). Besides all the research done to identify the causes what we know is that adrenalin is released into the blood stream as soon as a chemical substance is delivered intravenously. Adrenalin may play an important role in starting the cycle that ends up recognizing the chemical intruder and helps build resistance. It is important that the adrenergic reaction caused by the administration of a low dose of insulin and the concomitant administration of chemo drugs is properly managed. Learn how to manage the adrenergic reaction by attending a workshop update on IPT/IPTLD.

-Dr. Donato-


What it means to be a Certified IPT Practitioner There is a difference between “also do IPT” and being an “IPT professional”. You become an IPT professional by really looking into the procedure, using the side treatments, what other doctors do in IPT and Donato’s 82 years experience of his family: The aim is to become virtuous. Most doctors do an initial 2 day training seminar then go out and create homepages presenting themselves as the inventors. When I’ve visited them and looked at what they are doing; it is terrible. Even the nurse cannot check the blood sugar correctly (blood mixed with alcohol on the fingertip) and the doctor does not know what is going on. In order to compensate they construct a treatment monster of 5 different things under the motto thinking “something is going to work”. Unfortunately the patients tend to think the same and are thankful in the beginning but then it becomes expensive and they quit after the "8th treatment", running out of money saying “it did not work”. I am not trying to impose. What I am asking for is respect and honor to the years spent by my family and myself, and to allow me the opportunity to present and share scientific research and advancements. I am also asking for a team of physicians and medical professionals to join together and grow upon what has been accomplished so far. We can accomplish this together, as minds working toward the same goal for the advancements in IPT. One of the Academy’s goal is to create a standard IPT technique and establish stronger guidelines. It is common for patients to receive false therapies and dangerous protocols advertised as “IPT”. This hurts the very core of the IPT/IPTLD foundation. When you were trained in the IPT technique, you were required to follow guidelines. No one should take off with information and then use it the way they see best, disregarding the recommendations which were taught. I welcome your comments, ideas and thoughts. I ask this from every physician. However I do not ask that everyone claims IPT to be their own. That was never the intention of any member of the Donato legacy.

Our intention is to move forward with the betterment as a whole and I only ask a listening ear and respect during the process.

Our intention is to move forward with the betterment as a whole and I only ask a listening ear and respect during the process. Of course a doctor can continue to use the letters IPT. However, if they claim to use the trademarked protocol, using papers and information from magazines and books, it must be understood that there are administration rules to follow, as Dr. Donato Pérez García teaches and practices. If guidelines are not followed, where is the support for the technique being used? Again, I wish to move beyond the ‘I am the only one' or ‘I am the best’ and further the teachings of IPT. The Academy is open to interested doctors. Yes, I hold the legal rights, copyright and manual to IPT / IPTLD. This is not to say I hold nor want to claim the right to all future advancements. Instead of being combative, please join the Academy. The IPT technique has been in use since 1930. Many substances and delivery methods have been tested since then, some did not produce the expected or better results, today what we must do is adhere to a standard protocol. Then we can give information about what substances are best combined, in what time frame; which is best to use or not to use. If someone chooses to open their own school about IPT, I ask that they do not use my name, my family name and/or references to the name. Many long hours and hard work is behind this work; this requires respect and honor.

by Thomas Kroiss, MD Donato Pérez, MD


Next Video Call will be Sunday JUNE 16th 5:00 pm European Central Time

All Members Are Invited! Please Register to Microsoft Teams and Join! Be Online at the appointed date and time schedule in your part of the world We have members from all over the globe joining our video calls

For more information please write: education@iptldacademy.org


IPT

l

a n r u Jo

Introducing the IPT JOURNAL An exclusive Digital Publication for IPT Academy members

Stay conected to colleagues all over the globe in over 13 countries Learn the history behind IPT and its Founder

Sign up for IPT Seminars and Workshops Learn the Latest News on our Annual IPTGlobal Conferences

Read Medical Essays by Academy Members Keep updated on IPT Protocol Updates Share and Give your experience as an IPT Physician

AND MORE ...


Annals of Clinical Case Reports

Case Series Published: 11 Apr, 2019

A New Treatment Method of Advanced Metastatic Tumors Damyanov C*, Maslev I, Pavlov V and Todorov A Medical Center for Integrative Medicine, Bulgaria

Abstract The experience gathered in the more than seven decades of applying the reductionist approach to the treatment of oncological diseases has not justified the hopes and enormous financial expenses invested in it, as it has not brought about any significant breakthrough in the treatment efficacy. The tumour’s heterogeneity, resistance and adverse effects, combined with the high cost of applying either chemotherapy or target therapy have been the major factors limiting the treatment efficacy all of which are serious grounds for a reason to reassess the reductionist approach. In an attempt to apply the systematic approach principles to the oncological diseases treatment we turned to the opportunities offered by and the achievements of integrative oncology. Based on the results demonstrated so far from the successful application of the Insulin Potentiated Therapy (IPT) in our practice and following a long research period we developed a new protocol for complex treatment of advanced metastatic tumors, whereby the leading methodology is a combined application of IPT and Biomagnetic Pairs Therapy (BPT). Until October 2018 ten patients with advanced metastatic tumors (Т3-4 N1-2 M1-2) were involved in a combined IPT and BPT treatment. The tumors localisations being: four breast tumors, three rectal tumors, two cervical tumors and one ovarian tumor. The treatment of one of the patients was discontinued following his express wish. In two patients (the cases considered here) a full clinical remission was established. In three patients a partial therapeutic effect was registered. Their therapies continue with an outpatient treatment protocol. The treatment of the rest of the patients is still in progress, with their condition being stabilised. The results achieved so far albeit preliminary give us grounds and hope that our efforts will contribute to bringing the medical community’s focus on the need for further development and application of the systematic approach to the treatment of oncological diseases.

OPEN ACCESS *Correspondence: Damyanov C, Medical Center for Integrative Medicine, Deliiska Vodenitza Street, Bl. 330, 1592 Sofia, Bulgaria, E-mail: integramed@mail.bg Received Date: 20 Mar 2019 Accepted Date: 05 Apr 2019 Published Date: 11 Apr 2019 Citation: Damyanov C, Maslev I, Pavlov V, Todorov A. A New Treatment Method of Advanced Metastatic Tumors. Ann Clin Case Rep. 2019; 4: 1647. ISSN: 2474-1655 Copyright © 2019 Damyanov C. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Advance metastatic tumors; Insulin potentiation therapy, Biomagnetic pairs therapy; Goiz biomagnetic pairs

Introduction All statistical data demonstrate that the increasing oncological morbidity and mortality, i.e., the treatment’s low efficacy, remain an unsolved and an ever deepening crisis of not only medical, but also of world-wide social and economic dimensions. The hundreds of billions of dollars spent in the last decades (mainly for developing new chemicals) in “fighting cancer” notwithstanding, improvement in the survival rate of cancer patients has been registered for a few types of cancer only according to the Annual Report to the Nation on the Status of Cancer, 1975 to 2014. It has become clearer than ever that the conventional concept based on the reductionist approach that is fundamental to the traditional treatment of cancer can no longer satisfy the requirements of contemporary medical science, let alone the patients’ expectations [1-3]. The recent achievements in molecular biology gave rise to yet another hope for a breakthrough in the cancer treatment efficacy with the widely advertised target therapy. However, a multitude of problems which are having to do with the tumours’ heterogeneity and resistance to drugs, adverse effects and the high price of the target therapy procedures proved once again the necessity of reassessing the reductionist approach and directing the medical community’s attention to a radical change in the cancer treatment concept [1,4-6]. Therefore in an attempt to contribute to solving the problems discussed, we turned to applying the instruments of the systematic approach to cancer treatment, particularly to integrative oncology’s techniques and possibilities. Seeking non-toxic and efficient treatment methods in 2016 we introduced IPT in our clinical practice. The results

Remedy Publications LLC., | http://anncaserep.com/

1

2019 | Volume 4 | Article 1647


Damyanov C, et al.,

Annals of Clinical Case Reports - Oncology

thus obtained demonstrated the possibility to suspend the tumour’s growth and improve the patients’ quality of life in about 80% of the cases [7-9]. Further, based on some of the latest achievements in the field of tumoral pathogenesis, we began searching for novel non-toxic and effective methods affecting the processes of carcinogenesis. Our attention was drawn by the BPT developed by Dr. Isaac Goiz Duran in 1988 and his hypothesis of microbial association of intracellular reproducing bacteria and viruses although these are yet to be supported by rigorous scientific proof [10-12,13]. During a long period of research and having carefully and exhaustively studied the available information on the BPT we proceeded to the practical application of a protocol devised and developed by us for a complex treatment of advanced metastatic tumours based predominantly on IPT and BPT. Concerning the BPT this part of our protocol was based on the information available in four sources namely, 205th International Course on Medical Biomagnetism, March 2014, San Francisco, USA; Biomagnetic Pair Handbook (biomagnetism.net/training-course); and Book of Biomagnetic Pairs (Dr. Mario Ricardo Rodríguez Ramírez) and Dr. Cristobal Pin- Spain, Madrid (April 2018, Sofia, Bulgaria) [12,14].

Figure 1: Biomagnetic therapy with magnetic pairs.

b)

-Specific tumor pairs -Tumor phenomenon+tumor conflict

In the period December 2016 to October 2018 the treatment was applied to ten patients with advanced metastasised tumors. In the current presentation we only report the first results of the combined application of IPT and BPT in two cases. The complementary treatment included dietary therapy, antioxidant therapy, immunotherapy, ozone therapy and Pulsed Electromagnetic Field (PEMF) therapy. The methodology of IPT application was described in our prior publications [7-9].

PEMF-procedure for body polarization

Scanning and balancing of reservoirs and regular magnetic

Remedy Publications LLC., | http://anncaserep.com/

4.

Home treatment program

a)

Tumor drainage (Tumor phenomenon+tumor conflict)

Control test: in four weeks Basic information sources Biomagnetism training course - http://biomagnetism.net/ training-course/ Mario Ricardo Rodríguez Ramírez, Book of Biomagnetic Pairshttp://en.univich.com/product/book-ofbiomagnetic-pairs/ Once the Quick Program was completed the treatment was continued with IPT with six to ten applications once a week. In order to select the medicaments and supplements prior to and during the treatment we used modification of Prof. Omura muscle testing [15].

Case Series Case 1

The intervals between the procedures could be any longer

a)

Scanning and balancing of:

b) Magnetic pairs for immune system stimulation and emotional balance.

d) Quick Program C (according to the Dr. Mario Ricardo Rodriguez’ protocol)+magnetic pairs for emotional balance 6th to 7th day;

pairs

b)

Basic program continues until the magnetic imbalance clearance. If necessary the symptomatic treatment is included (according to the Dr. Mario Ricardo Rodriguez’ symptomatic list).

c) Quick Program B+C (according to the Dr. Mario Ricardo Rodriguez’ protocol)+magnetic pairs for immune system stimulation 3rd day;

Basic program-2nd week

Scanning and balancing of reservoirs and regular magnetic

-Magnetic pairs for immune system stimulation and emotional balance

b) Quick Program А (according to the Dr. Mario Ricardo Rodriguez’ protocol)+magnetic pairs for emotional balance 1st day

2.

a)

-Tumor phenomenon+tumor conflict

Protocol for biomagnetic therapy with magnetic pairs for treatment of oncology diseases

a)

Basic program-3rd week

-Specific tumor pairs

In the first week, the treatment protocol involved BPT in combination with ozone therapy and PEMF therapy. The BPT treatment comprised the Quick Program A; В+C and C of Dr. Mario Ramírez at two-day intervals followed by the basic protocol (reservoirs+regular pairs, tumor phenomenon, magnetic pairs for immune system stimulation) once a week, until the magnetic disbalance was cleared (Figure 1).

Preparatory program-1st week

3. pairs

Methods

1.

Scanning and balancing of:

M D K is a 42-year old female patient who underwent surgery in November 2016 for a histologically-verified right breast carcinoma, namely invasive ductal carcinoma. Right unilateral mastectomy has been performed and the case has been assessed as T2N1M1. The patient was admitted to the clinic for treatment in December of 2

2019 | Volume 4 | Article 1647


Damyanov C, et al.,

Annals of Clinical Case Reports - Oncology

Figure 2: Case one: PET/CT before and after the treatment.

Figure 3: Case Two: PET/CT before and after the treatment.

the same year with major symptoms as follows: weight loss, severe pain in the waist area and the limbs and strongly restricted motor activity. The initial Karnofsky performance status was 70, while the Beretta symptomatic index for quality of life was 24 points. Prior to the treatment, the results of the laboratory test were as follows: HGB 118 (R 120 to 160); RBC 3.76 T/l (R 3.9 to 6.5); ESR 45 mm (R<15); alkaline phosphatase 592 U/l (R<240); СЕА 15-3-49.27 U/ml (R<25). The PET/CT prior to the treatment indicated lymphatic and generalised bone metastases.

performed autonomous muscle testing. As a complementary outpatient treatment we prescribed dietary therapy, immunotherapy and supplements in accordance with the muscle testing outcome. The number of IPT procedures reached 37 while that of BPT totaled 28. After February 2018 the patient’s condition improved significantly the pain diminished and the motor activity began increasing gradually. After April 2018 the pain vanished while the motor activity fully recovered. The laboratory test results indicated normalisation of all parameters including the tumor marker. The value of the symptomatic index for quality of life dropped from 24 to 1 point.

In December 2016 BPT was started following the biomagnetism. net/training-course. In February 2017 in the course of treatment the pain symptom gradually increased. In order to overcome it IPT was included at one-week intervals. The pain syndrome decreased upon the sixth application, after the tenth application the pain disappeared while the motor activity was recovered to a large degree. The treatment was terminated because of the express wish of the patient.

A controlling PET/CT was performed in May 2018 with the following results: thorax and lungs-no indications for metabolicallyactive no dose lesions in the parenchyma of both lungs and the breast; absence of metabolically-active lesions in the bones; indications for a metabolically-active soft-tissue lesion right-parasternally at the 2nd to 3rd intercostal level, adjacent to which micro calcifications are observed; absence of metabolically-active lesions in the lymph nodes. Under ultrasound control biopsy was carried out of the parasternal lesion in view of clarifying its state - no signs of a malignant process were observed (Figure 2).

However in August 2017 the patient’s condition having worsened the treatment was resumed at one-week intervals with an IPT and BPT combination under a new revised by us program. The IPT applications consisted of three-component drugs combinations comprising Endoxan, 5-Fu, Epirubicin, Cisplatin, Methotrexatе, Vinorelbine, Etoposide, Carboplatin, Taxotere in a dosage ten times as low as the standard one. In order to select the chemo drug combination each IPT application was preceded by autonomous muscle testing. The drugs combinations were modified several times during the treatment due to resistance to some of the chemo drugs. These corrections were made under the control of periodically

Remedy Publications LLC., | http://anncaserep.com/

As of May 2018 the patient was in a state of complete clinical remission. The case presented above was included for treatment at the end of our research period which resulted in the development of our own protocol for BPT. This is why a larger number of therapeutic

3

2019 | Volume 4 | Article 1647


Damyanov C, et al.,

Annals of Clinical Case Reports - Oncology

Recently our attention was caught by studies on the symbiosis of the epithelial barriers and the microbiome as a decisive factor in the development and treatment of tumors [16,17]. The scientific data accummulated so far on the role played by intracellularly reproduced microorganisms in the tumoral genesis and development as well as by the inflammatory processes led us to the idea of seeking new possibilities of influencing efficiently both the microbiome and the inflammatory processes in the course of an individual therapeutic program. Among the novel methods our interest was particularly drawn by Dr. Goiz’s hypothesis and theory on the BPT’s therapeutic effects.

procedures were necessary. Case 2 In May 2018, V I M a 41-year old female patient was diagnosed with right-breast carcinoma. She was recommended for surgery. A month later as recommended by us a PET/CT was performed. The results indicating a bifocal tumour of the right breast engaging of the ipsilateral limph nodes and generalised bone metastases. The histological examination showed highly to moderately differentiated infiltrative ductal carcinoma (T4N1M1). The patient refused the proposed chemotherapy. She was admitted to the clinic with complaints of severe pain in the neck and pelvis.

In 1988 Dr. Isaac Goiz Duran, (Mexican physical therapist) laid the foundations of a new medical science-the Biomagnetism and built the concept and theory of BPT. This theory and its practice were based on the scientific research of Dr. Richard Broeringmeyer of NASA for the role of the magnetic field in the human body. He reached the conclusion that the organs and tissues in human have a magnetic polarisation which is connected with the body’s pH index (acidity or alkalinity) [10-13,17].

The visual examination of the right breast showed pigmentation and skin retraction in the areola. A tumor formation could be palpated in the same area with a size of approximately 20 mm. The Karnofsky performance status before the teatment was 70 while the symptomatic index for quality of life was 26 points. The laboratory blood and biochemistry test results were within the reference values but СА 15-3-51, 8 U/ml (R<25). In June 2018 we started a treatment including BPT in combination with ozone therapy and PEMF. After the first week IPT was included consisting in seven application in one-week intervals. The administered drugs were Endoxan, Ifosfamid, 5-Fu, Cisplatin, Epirubicin, Vinblastine, Vinorelbine and Methotrexate in a dosage ten times as low as the standard one. During the therapy course the chemo drugs had to be modified in accordance with the muscle testing results. As a complementary outpatient treatment we prescribed dietary therapy, antioxidant therapy, immunotherapy, ozone therapy, and PEMF. To deal with a dominating psycho-emotional disbalance we included homeopathy, Reiki procedures and magnetic pairs for emotional disbalance.

According to Dr. Goiz a disturbance in the alkalinity/acidity balance creates a medium favouring the development of viruses, bacteria, fungi and parasites. Scanning the body by magnetic pairs allows us to discover a magnetic disbalance which is indicative of a changed pH and correspondingly the presence of an infection. Further the viruses and fungi exist in a symbiotic relationship while the bacteria are parasites. A bacterium and a viruse resonate between one another which causes a disease; depending on the specific disease one is pathogenic and the other-apathogenic. Bacteria and parasites live and grow in alkaline media while viruses and fungi in acidic media. Based on these hypothetical considerations Dr. Goiz built his BPT. It comprises two main components, body scanning in view of finding magnetic pairs with disturbed polarity in different body zones followed by a treatment phase whereby permanent magnets are placed and kept for 25 min to 30 min.

In the course of therapy the general and the psycho-emotional states improved, the pain subsided considerably while the areola deformation disappeared. The value of the Beretta symptomatic index for quality of life index fell from 24 to 1 point. The control laboratory test i pointed to a normalisation of the tumour marker, CA 15-3 from 51.8 down to 13 U/ml (R<25), and of the alkaline phosphatase, from 445 U/l to 56 U/l (R<105). Further the control PET/CT carried out in September indicated the complete absence of metabolicallyactive lesions. Thus as of November 2018 the control examinations demonstrated a complete clinical remission (Figure 3).

Dr. Goiz’s research led him further to concluding that cancers have their origin in the symbiosis of various viruses and bacteria. The association of pathogenic bacteria + pathogenic bacteria+pathogenic virus+ Mycobacterium leprae results in a malignant process. All tumoral processes including the malignant ones are caused by combinations of various pathogenic factors and can be diagnosed by means of magnetic scanning. According to the Dr. Goiz’s theory the following factors are the root causes of tumorigenesis:

Discussion

1. Inflammation factor or factor damaging the cellullar membrane and nucleus. A pathogenic virus;

In searching for new opportunities of improving the overall efficacy of our clinical practice particularly concerning the metastatic tumors, we concentrated our efforts on two major field's namely diagnostic techniques offering individualised selection of medicaments in cancer treatment and efficient therapeutic methods suitable for combining with the leading treatment method in our practice-the IPT. Successively we introduced a method for selecting antitumoral medicaments using genetic testing of isolated circulating tumor cells (Biofocus, Germany) and autonomous muscle testing for selecting appropriate medicaments and treatment methods based on the research and practice of Prof. Omura and Dr. Goiz. The experience acquired so far by us in applying the two diagnostic methods indicated a similar performance in 80% to 90 % of the cases. Thus using both diagnostic tests allows us to prepare individualised therapeutic programmes for the patients treated to the clinic [15]. Remedy Publications LLC., | http://anncaserep.com/

2. Localisation factor-pathogenic bacteria localised in a biomagnetic pair or elsewhere, thus determining the tumor localisation in the body. E.g., Proteus mirabilis localised in the mediastinum may cause cancer of the oesophagus, while Enterobacter cloacae in the colon-intestinal cancer; 3. Delayed tumor growth factor-another bacterium determining a slower tumor growth;

pathogenic

4. Fast (explosive) tumor growth factor-presence of a fungus causing certain tumors to grow faster than other; 5. Malignancy factor-presence of Mycobacterium leprae; According to Dr. Goiz, the absence of Mycobacterium leprae as established by magnetic-pair scanning points to the presence of a 4

2019 | Volume 4 | Article 1647


Damyanov C, et al.,

Annals of Clinical Case Reports - Oncology

different formation, like an abscess or a haematoma, rather than a tumor;

controlled clinical conditions the capabilities of the IPT with those of the BPT demonstrated for the first time the synergy arising from applying simultaneously the two methods. Furthermore in addition to our protocol’s anti tumorial efficacy we must emphasise the absence of toxic adverse effects and its low cost i.e. its accessibility.

6. Metastasis factor-the anaerobic bacteria Рseudomonas and Chlostridium cause metastases; 7.

Necrosis factor-presence of parasites [12,13,18].

It is our belief that the first although preliminary results obtained by us will play a noteworthy part in convincing the medical community to appreciate the necessity of considering the further development and application of the systematic approach to the treatment of oncological diseases.

Relying on his practical experience and achieved results, Dr. Goiz affirms that the BPT leads to a full reversal of the tumoral process even in an advanced stage of the ailment. A failure can be expected in the cases of preceding chemo or radiotherapy or of unstable psychological state.

We also believe that these results form the basis of further activities on optimising our therapeutic methodology. Thus accumulating sufficient experience worthy will be presented to the medical community in future publications.

Unfortunately rigorous scientific proof still lacking the above considerations remain in the realm of the hypothetical. Despite this method’s huge popularity particularly in South America, but increasingly also in North America, the conventional medicine has turned its back to this treatment’s demonstrated capabilities, and, with a few exceptions, no clinical tests have been reported that would prove or refute its therapeutic value.

Authors Contributions Ch D, IM, VP and LA wrote the manuscript and revised the manuscript. All authors read and approved the final manuscript.

Acknowledgement

Faced with a number of difficulties of informational nature, the final version of our BPT protocol was completed in April 2018 after a four year research period. Then until October of that year ten patients with advanced metastatic tumours (Т3-4N1-2 M1-2) were treated by IPT in conjunction with BPT. The malignant formations included four breast tumors, three rectal tumors, two cervical tumors and one ovarian tumor.

The authors evince acknowledgments to Dr.Donato Perez Garcia for his obligation related to the introduction of Insulin Potentiation Therapy in our clinical practice. The authors are also grateful to Mrs. Iveta Pashina for her assistance in the application of the Biomagnetic therapy with Magnetic Pairs in our clinic. as well as for creation of treatment protocol with Magnetic Pairs for patients with metastatic cancer.

In one of the cases the treatment was stopped following the patient’s express wish. In two cases (presented here) the therapy resulted in a full clinical remission. In three cases we registered a partial therapeutic effect; their treatment is ongoing with a program of outpatient therapy. The remaining patients are still hospitalised and treated but in a stable condition.

References 1. Maeda H, Khatami M. Analysis of repeated failures in cancer therapy for solid tumors: poor tumor-selective drugs delivery, low therapeutic efficacy and unsustainable costs. Clin Transl Med. 2018;7(1):11. 2. Stensland KD, McBride RB, Latif A, Wisnivesky J, Hendricks R, Roper N, et al. Adult cancer clinical trials that fail to complete: an epidemic? J Nat Cancer Inst. 2014;106(9)1-6.

The treatment’ adverse effects are negligible and consist in weariness and drowsiness on the days of IPT administration. One patient only experienced nausea and vomiting for a couple of hours on the days of IPT treatment. No adverse effects were observed during the BPT application.

3. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109(9).

In the cases of the first two patients the start of the therapy coincided with the end of the BPT research period when our protocol was still not fully completed. Thus together with the treatment interruption following the patient’s wish imposed an extension in the treatment period with additional IPT and BPT applications. Finalising the protocol allowed us when treating the other patients to reduce considerably the number of procedures and thus the treatment duration.

4. Joo WD, Visintin I, Mor G. Targeted cancer therapy-are the days of systemic chemotherapy numbered? Maturitas. 2013;76(4):308-14. 5. Saijo N. Present status and problems on molecular targeted therapy of cancer. Cancer Res Treat. 2012;44(1):1-10. 6. Prasad V, Mailandkody S: How should we assess the value of innovative drugs in oncology? Lessons from cost-effecvtiveness analyses. Blood. 2015;126:1860-1. 7. Damyanov C, Radoslavova M, Gavrilov V, Stoeva D. Low dose chemotherapy in combination with insulin for the treatment of advanced metastatic tumors. Preliminary experience. J BUON. 2009;14(4):711-5.

Finally the results of the biopsies carried out during the course of the therapy revealed intriguing morphological changes. These necessitate and will be the object of further studies.

8. Damyanov C, Gherasimova DM, Avramov LA, Masley IK. Insulin potentiation therapy in the treatment of malignant neoplastic diseases: a three year study. J Cancer Sci Ther. 2012;4:88-91.

Conclusion Presenting the first results of applying the combined therapy protocol, conceived and developed by us we do not pretend to put into doubt or competes with the achievements of molecular biology. We simply wish to illustrate the potential of one possible way of changing the reductionist approach concept for cancer treatment.

9. Damyanov C, Gerasimova D, Maslev I, Gavrilov V. Low-dose chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer. ISRN Urology. 2012;2012;1-6. 10. Bailey J. Bioenergetic basics: The art of dynamic wellness with Goiz biomagnetic pairs. Leslie Maria Cramer, Lucinda Hilbrink, editors. Charleston: Booksurge Publishing; 2010.

To the best of our knowledge, besides pointing to the opportunities offered by the BPT in cancer treatment, our attempt to join under Remedy Publications LLC., | http://anncaserep.com/

5

2019 | Volume 4 | Article 1647


Damyanov C, et al.,

Annals of Clinical Case Reports - Oncology

11. Sánchez G. Health and medical biomagnetism. Biomagnetic pair. 1st ed. Washington DC: Library of Congress United States of America; 2011.

16. Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33(4):570-80.

12. Biomagnetism training course. The international center for the study and outrech of natural therapies. Madrid.

17. Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science. 2018;359(6382):1366-70.

13. Isac Goiz Duran. El Fenomeno Tumoral. 3 ed. Texcoco: Universidad Autonoma Chapingo; 2000. rd

18. Elle Molineux. Biomagnetism training course. Ontario: Elle's Integrated Wellness.

14. Mario Ricardo Rodríguez Ramírez. Book of Biomagnetic Pairs. Jalisco: Chilife Virtual University; 2019. 15. Chr Damyanov, Vl Pavlov, Iv Maslev. Personalized Treatment Aplication in Integrative Oncology, Pariplex - Indian J Res. 2018;7(1):531-4.

Remedy Publications LLC., | http://anncaserep.com/

6

2019 | Volume 4 | Article 1647


XV IPT GLobal Conference 2019 “Managing metastatic lesions using IPTLD®”

Fulda, Germany October 5 and 6

Medical Doctors, Nurses and other health care professionals, you are all welcome to attend our annual IPT Global Conference 2019 in Fulda, Germany on October 5 and 6. There will be a training seminar with Dr. Donato Pérez García for those who wish to become official IPT Physicians, there will be many known speakers giving presentations on topics as LITT/chemo-embolisation, molecular-genetic testing, albumin-enhanced cytostatics, the importance of mental healing and more. You are welcome to join, please contact us: education@iptldacademy.org

European Academy for Inslin Potentiation Therapy www.iptldacademy.org

Official ipt education and certification by Donato Pérez García.


XV IPT GLobal Conference 2019 “Managing metastatic lesions using IPTLD®” CONFERENCE PROGRAM October 4th

October 5th

Personal IPT Education Seminar by Donato Perez Garcia MD If you want to become a Licensed IPT/IPTLD practitioner or update your IPT/IPTLD knowledge. Lectures will include correct finding of insulin dose, prevent the adrenergic reaction , managing hypoglycemia, cytostatics,reducing chemo resistance and more. There is so much to learn from Dr. Donato Perez Garcias, who has more than 3 decades experience in treating patients with IPT. Do not miss this opportunity. Places are limited to 10! Join The Academy for IPT and Register to take advantage of being listed in the Academy for IPT website Directory of Certified Practitioners.

October 6th

TACE / LITT as complementary Prof. Thomas Vogl, Univ. of Frankfurt

Intravenous Oxygen in cancer treatment Dr. Wiechert, Germany

Molecular genetic testing and its value in cancer therapy Prof. Hans Bojar / Univ. of Düsseldorf

Albumin bound MTX (MTX-HSA) Dr Trennheuser & Dr Freudsmiedl Heavymetals & Chelatation in Cancer treatment Prof. Eleonore Blaurock-Busch

Use of low-dose checkpoint inhibitor in combination with IPT Dr. Thomas Nesselhuth

IPT with non-chemotherapeutics Akbar Khan MD, Canada

Complexities of managing metastatic disease with IPT Donato Perez Garcia MD, Mexico

metronomic chemotherapy concurrent with IPT Dr. Geoffrey Huertgen, CH

Panel Discussion: learning from responders and non-responders case-reports

Supported by HELIXOR - mistle toe OXYVEN European Academy for IPT

Academy Annual Meeting IPT-award

WHERE?

A beautiful City in Hesse, Germany; it is located on the river Fulda and is the administrative seat of the Fulda district (Kreis). It’s known for baroque buildings like Fulda Cathedral.

For hotel booking ESPERANTO Hotel Esperantostraße, 36037 email to info@hotel-Esperanto.de or order by phone +49-661-24291-0

Easy access One hour from Frankfurt Airport located 2 minutes from trainstation 5 minutes by car from Autobahn A7.

REGISTRATIONS

For training and official certification Send your training request to Dr. Donato: drdonato3@iptlmd.com Or register directly at: https://www.eventbrite.com/e/ipt-training-seminar-october-42019-fulda-germany-tickets-536 72006416

* Join our Worldwide Community. * Training, learning and education. * Exchange your experience. and improve your medical skills. * Meet colleagues and friends from all over the world. * Become a member of our IPT Academy. *Get official certification in the IPT medical protocol.

Registrations for the 15th Global IPT Conference 2019: https://www.eventbrite.com/e/2019-insulin-potentiation-therapy-conference-fulda-germany-tickets-536 72716540#tickets

WELCOME DOCTORS! www.IPTLDACADEMY.org


2019

IPT Global Conference October 5 and 6 in C

Fulda, Germany

Scan QR for Registration Link Hotel Esperanto, Esperantoplatz 36037 Fulda, Germany

Fulda Here We Come!


2019

IPT Training Seminars and Workshops with Dr. Donato

Scan QR for Registration Link or go to: https://www.eventbrite.com/ e/ipt-training-seminaroctober-42019-fuldagermany-tickets-53672006416

Pre-Conference Training Seminar Friday October 4 IPTLD/IPT Basic Seminar training with Dr. Donato Pérez García WHERE: Fulda, Germany a day prior to the IPT GLobal Conference.

Seminars in English

Seminarios en Español

April 22 – 26 September 2 – 6

Mayo 13 – 17 Octubre 21 – 25

WHERE: Department of Functional Medicine at Hospital Angeles Tijuana, Mexico.

WHERE: Department of Functional Medicine at Hospital Angeles Tijuana, Mexico.

To Register for any of these please write to:

drdonato3@iptldmd.com


DOCTOR! WE WANT TO READ YOUR WORK. PLEASE SEND US YOUR MEDICAL ARTICLE TO: education@iptldacademy.org

All IPT Academy Members are welcomed to send us their medical articles to be publish in this e-Magazine! Requirements: * All articles must be original and written by IPT Academy Members only. * In English Language. * Limit length to 2 letter size pages max. * Copyright disclaimer by the author.


Become a Trained Physician in the Protocol Insulin Potentiation Therapy Low Dose®

“ A lighter way to do chemo”

Traditional Chemo

Vs. IPTLD®

www.IPTLDACADEMY.org

Profile for IPTACADEMY

IPT JOURNAL -MAY-  

Third Issue of our electronic magazine for members of the European Academy for Insulin Potentiation Therapy.

IPT JOURNAL -MAY-  

Third Issue of our electronic magazine for members of the European Academy for Insulin Potentiation Therapy.